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APPEARANCE OF SPERMATOZOON AFTER 
ADMINISTRATION OF MAST CELL BLOCKER 
TO A PATIENT WITH AZOOSPERMIA 
Masanori Yamamoto, Hatsuki Hibi and Kcji Miyake 
From the Department of Urology, Nagoya University School of Medicine 
Since a close relationship has been suggested to exist between testicular disfunction and the 
increased mast cells in the testis, we used a mast cell blocker for the treatment of patients with 
idiopathic infestility. An infertile male with idiopathic azoospermia was treated with administra-
tion of a mast cell blocker, tranilast for one year. The patient was found to have sperm within 
his ejaculate. However, the ultimate goal of pregnancy was not achieved by the microfertilization 
technique. To evaluate the possible significance of this new treatment, further basic research will 
be needed to clarify the relationship between mast cell proliferation and impaired testicular func-
tion. 
(Acta Urol. Jpn. 40: 541-543, 1994) 
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INTRODUCTION 
A new approach for the treatment of 
male infertility focuses on the role of mast 
cell blockers which inhibit the release of 
histamine and other vasoactive substances 
from mast cells. The rationale of this 
approach is based on the observation of 
mastocytosis in the testes of infertile males 
which was first reported by Maseki et all). 
The increase in mast cells in the infertile 
testis may indicate some relationship bet-
ween mast cell proliferation and testicular 
dysfunction. Hofmann et aJ.2) and Schill 
et a1.3) reported in a pilot study positive 
effects of Ketotifen, a mast cell blocker, 
on semen parameters in infertile men. 
Therefore, we administered tranilast, a 
mast cell blocker, to idiopathic azoosper-
mic men to determine whether this kind of 
treatment may have a beneficial effect on 
the semen quality. Here we report the 
first clinical case of sperm emergence after 
administration of a mast cell blocker in 
the patient with azoospermia. 
CASE REPORT 
A 25-year-old male presented with azoos-
permia diagnosed by semen analysis on 
three separate occasions (average pH 7.5; 
average volume of 3.2 mL) over the course 
of I year. Laboratory evaluation revealed 
a normal follicle-stimulating hormone (8.2 
mIU /ml), luteinizing hormone (5.2 mIU / 
ml), testosterone (5.8 ng/ml), prolactin (9 
ng/m!), and thyroid functions. The peri-
pheral lymphocyte karyotype was 46,XY. 
Physical examination revealed normal se-
condary sex characteristics, normal phallus 
with a normal meatus and bilaterally des-
cended testes measuring 15 ml on the left 
and 18 ml on the right. There was a small 
left varicocele. Rectal examination was 
normal. The patient underwent a bilateral 
testicular biopsy and high ligation of the 
gonadal vein. 
On testicular biopsy, approximately 80% 
of the tubules contained only Sertoli cells 
and a slightly thickened tunica propria, 
and about 20% of the tubules showed 
incomplete maturation arrest without 
peri tubular thickening. Only occasional 
tubules had germ cells present with varying 
stages of spermatogenesis. Leydig cells were 
seen in slightly increased numbers (Fig. I). 
Follow-up monthly semen analysis post-
operatively still revealed azoospermia up to 
3 years later. The patient and his wife 
were offered donor insemination for a 
pregnancy attempt but they declined. 
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Fig. I. Testicular biopsy demonstrating 
predominance of Sertoli cells. 
Treatment with tranilast was started at 
doses of 300 mg/day for 6 months. There 
was no adverse effect of this drug on 
regular laboratory check up. A subsequent 
semen analysis revealed 700,000 sperm/mL 
with 35% motility (total volume was 2.6 
mL) . Endocrine profiles six months after 
administration of tranilast were as follows; 
FSH: 7.4mIU/ml, LH: 3.2mIU/ml, testos-
terone: 9.2 ng/ml, prolactin: 8.2 ng/m!. 
The treatment was continued for up to 12 
months. Semen analysis was repeated 
every three months, but the sperm count 
did not improve further. No pregnancy 
was achieved. Not enough motile sperm 
were present to perform routine in vitro 
fertilization (IVF). This couple under-
went microfertilization by using the partial 
zona dissection technique, but the proce-
dure was unsuccessful. 
DISCUSSION 
Maseki et al. were the first to find that 
mastocytosis occurred in the testes from 
the patients with idiopathic infertilityD. 
Hashimoto et al. demonstrated that the 
number of mast cells was increased not 
only in the interstitium but also in the 
lamina propria of the seminiferous tubu-
les4) . Nagai et al. attempted to determine 
the heterogeneity of mast cells in the tes-
tes from the patients with idiopathic infer-
tility6). They demonstrated that the total 
number of mast cells and the ratio of 
chondroitin sulfate containing mast cells 
were significantly increased in the infertile 
testes6) , Peri tubular fibrosis is a common 
finding in the testicular biopsy specimen 
from the infertile males. Mast cells are 
known to induce fibrosis under certain 
conditions. The cytoplasmic granules of 
these cells contein numerous chemical me-
diators that can be released into the sur-
rounding tissues after certain allergic, im-
munological, and other stimulations and 
can result in various effects upon the tis-
sues involving the cells5). Thus, a close 
relationship is likely to exist between tes-
ticular disfunction and the increased mast 
cells in the testis. Despite the possible 
involvement of mast cells in idiopathic 
male infertility, their role in testicular tis-
seus remains to be elucidated 
Unfortunately, in this case, we did not 
perform a histochemical study of testicular 
biopsied specimen to identify mastocytosis 
in the testicular interstitium. However, on 
the basis of our previous findings, we used 
a mast cell blocker for the treatment of 
idiopathic infertile patients with the expec-
tation of a possible beneficial effect on 
semen quality. Administration of the mast 
cell blocker, tranilast, to men with idio-
pathic azoospermia for up to I year led to 
successful appearance of spermatozoa in 
the seminal fluid. This improvement can 
be explained by blocking of release of 
chemical mediators from mast cells which 
can induce some fibrotic process. Schill et 
al. reported hat treatment of idiopathic 
oligozoospermia by the mast cell blocker, 
Ketotifen, led to a very moderate, but 
statistical significant improvement of sperm 
count and sperm motility3) . However, 
the pregnancy rate was within the range 
of spontaneous conceptions3). They spec-
ulate that the release of chemical mediator 
within the testis plays some role in the 
pathophysiology of testicular disorders3). 
In conclusion, successful sperm output 
was observed after treatment with a mast 
cell blocker in an idiopathic infertile pa-
tient. To evaluate the possible significance 
of this new treatment, further basic re-
search will be needed to clarify the relation-
ship between mast cell proliferation and 
impaired spermatogenesis. 
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和文抄録
無精子 症患者 に対 しマ ス ト細 胞 プ ロッカーを
投与 し精子 の出現 を みた1例
名古屋大学医学部泌尿器科学教室(主任:三宅弘治教授)
山本 雅憲,日 比 初紀,三 宅 弘 治
　造精機能障害と精巣をおけるマスト細胞の増加との
問には密接な関係が存在する.この知見をもとに,特
発男子不妊症の治療としてマスト細胞プロッカーの使
用を試みた.特発性無精子症患者に対し,マス ト細胞
プロッカーの一種 であるtranilastを1年間投与し
た.その結果,精液中に精子の出現が認められた.顕
微授精を施行したが,妊娠には至らなかった.この新
しい治療法の意義を評価するために,マ スト細胞の増
加と精巣機能障害との関係を明らかにする基礎的な、
研究が必要である.
(泌尿紀要40:541-543,1994)
